Nadroparin 2850 IU | Libya (BAYADERCARE)
Convenient anticoagulant support for thrombosis management.
Nadroparin 2850 IU Prefilled Syringe | BAYADERCARE Libya
Trusted Solution for Critical CarePreventive anticoagulation plays a critical role in modern clinical practice, particularly in reducing the risk of thromboembolic complications in surgical and immobilized patients. Low molecular weight heparins (LMWH) are widely used in Libyan healthcare settings due to their predictable anticoagulant response and favorable safety profile.
NADROBARA® (Nadroparin Injection) is developed by RAWIA INTERNATIONAL HEALTHCARE (RIHCA) in collaboration with leading pharmaceutical manufacturing partners and is available across Libya through BAYADERCARE. The 2850 IU strength is specifically designed for thromboprophylaxis, supporting hospitals, clinics, and healthcare professionals in Tripoli, Benghazi, Misrata, and across Libya — To Share • To Care • To Inspire.
NADROBARA® 2850 IU (Nadroparin Calcium) is a low molecular weight heparin (LMWH) used primarily for prophylactic anticoagulation in patients at risk of thromboembolic conditions. It works by inhibiting factor Xa activity, reducing clot formation and supporting stable blood flow.
This strength is commonly used in preventive treatment protocols, particularly in surgical patients, immobilized individuals, and those requiring controlled anticoagulant support in hospital settings under medical supervision. Specifications Table| Parameter | Details |
| Brand Name | NADROBARA® |
| Generic Name | Nadroparin Calcium |
| Arabic Name | نادروبارا نادروبارين كالسيوم |
| Category | Anticoagulants |
| Therapeutic Area | Low Molecular Weight Heparin (LMWH) |
| Dosage Form | Prefilled Syringe |
| Strength | 2850 IU |
| Volume | 0.3 ml |
| Route / Type | Subcutaneous (Anti-Xa) |
| Developed By | RIHCA |
| Marketed By | RAWIACARE |
| Availability | Libya via BAYADERCARE |
| Official Libya Proxy | BAYADERCARE |
| Official Global Platform | RAWIACARE / RAWIACARE GLOBAL |
| Corporate Philosophy | TO SHARE • TO CARE • TO INSPIRE |
Applications / Uses
| Prevention of Deep Vein Thrombosis (DVT) |
| Post-surgical thromboprophylaxis |
| Anticoagulant support in immobilized patients |
| Prevention of venous thromboembolism (VTE) |
| Hospital-based preventive protocols |
Nadrobara Nadroparin Calcium 2850 IU Prefilled Syringe
Nadrobara Nadroparin Calcium 2850 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.
Nadrobara Nadroparin Calcium 3800 IU Prefilled Syringe
Nadrobara Nadroparin Calcium 3800 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.
Nadrobara Nadroparin Calcium 5700 IU Prefilled Syringe
Nadrobara Nadroparin Calcium 5700 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.
FAQ
Is NADROBARA 2850 IU available in Libya?
Yes, it is available through BAYADERCARE across Libya.
What is NADROBARA 2850 IU used for?
It is used for the prevention of thromboembolic conditions such as DVT in surgical and immobilized patients.
How does Nadroparin work?
It inhibits factor Xa activity, helping to reduce clot formation and maintain proper blood circulation.
Where is this strength commonly used?
Hospitals, surgical units, clinics, and healthcare centers.
What strengths are available?
| 2850 IU |
| 3800 IU |
| 5700 IU |